Hepatocellular Carcinoma and HCV Cure with DAAs: Update and Current Challenges
This hour-long webinar presentation will address the confusion about the association between HCV cure with DAAs and HCC risk, and will be followed by a question-and-answer session. This activity is intended for clinicians engaged in the care of patients with Hepatitis C and hepatocellular carcinoma. (Professional credits will be offered.)
Webinar is on Tuesday, 3/26, and will run from 7pm ET until 8pm ET.
Speaker: Hashem B. El-Serag, M.D., M.P.H.
Margaret M. and Albert B. Alkek Professor and Chair
Department of Medicine
Baylor College of Medicine